Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie R Brewer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|November 12, 2015
Chemotherapy-induced peripheral neuropathy: Current status and progressJamie R Brewer, Gladys Morrison, M Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapyLianne Hu, Chaohong Fan, Peter Bross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2020
An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate CancerMichael Brave, Chana Weinstock, Jamie R Brewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2023
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular CarcinomaTimil H Patel, Jamie R Brewer, Jiaxin Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work GroupR Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case StudiesJamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
The Lancet. Oncology|July 26, 2021
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Lijun Zhang, Anup Amatya, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|November 12, 2015
Chemotherapy-induced peripheral neuropathy: Current status and progressJamie R Brewer, Gladys Morrison, M Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapyLianne Hu, Chaohong Fan, Peter Bross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2020
An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate CancerMichael Brave, Chana Weinstock, Jamie R Brewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2023
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular CarcinomaTimil H Patel, Jamie R Brewer, Jiaxin Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work GroupR Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case StudiesJamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
The Lancet. Oncology|July 26, 2021
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Lijun Zhang, Anup Amatya, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Pageof 1